Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT04424732
Eligibility Criteria:
Inclusion Criteria:
* Women \>18 years old with a pathologically proven breast cancer who present with 1-3 bone metastases will be included.
* Metastases need to be confirmed pathologically if possible, otherwise two different imaging modalities (CTor MRI and bone scan or PET) are needed to confirm metastases.
* Patients should be able to receive the recommended local and systemic treatment and the primary tumor must be controlled at time of SBRT.
* Maximum diameter of individual metastasis metastasis in any dimension ≤ 5 cm; and must be \>5 cm away from each other (defined as Edge to Edge of tumor).
Exclusion Criteria:
* Non bone metastatic breast cancers
* Prior history of radiotherapy to same sites of SBRT
* Pathologic fractures of involved bones
* Contraindications to radiotherapy including pregnancy and connective tissue disease.
* Patients with impaired cognitive functions.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04424732
Study Brief:
Protocol Section:
NCT04424732